Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Cash flows from operating activities
Net (loss) income	$ (18,903,656)	$ 14,249,645
Adjustments to reconcile net (loss) income to net cash used in operating activities
Depreciation	22,164	10,724
Amortization	439,543	424,812
Amortization of debt discount	112,940	0
Deferred income tax benefit	(2,735)	0
Lease expense	41,950	15,870
Loss on disposal of property and equipment	0	135,600
Loss on operating lease right-of-use asset - lease abandonment	0	146,795
Loss on operating lease right-of-use asset - lease termination settlement	0	2,992
Stock-based compensation - employees	15,390,822	746,300
Stock-based compensation - non-employees	1,172,000	279,000
Stock-based settlement of accrued interest	54,657	0
Settlement of lighting patent purchase	1,331,814	0
Shares issued related to lease termination settlement	0	50,700
Shares issued for interest	135,166	159,300
Non-cash services expense	0	19,000
Change in fair value of patent acquisition liability	(971,500)	660,000
Gain on derecognition of debt	0	(21,179,043)
Foreign exchange loss	27,726	55,210
Changes in operating assets and liabilities which provided (used) cash, net of amounts acquired in 2021 business combination
Accounts receivable	14,174	0
Prepaid expenses and other assets	(16,956)	0
Income taxes	25,670	0
Other receivable	89,370	310,111
Accounts payable	143,934	(2,507)
Accounts payable – related parties	38,828	8,347
Accrued interest – related and non-related parties	514,155	3,441,595
Operating lease payments	(28,155)	0
Governmental assistance payable	146,144	0
Accrued expenses	(113,559)	124,800
Net cash used in operating activities	(335,504)	(340,749)
Cash flows from investing activities
Cash acquired upon acquisition of Clear Com Media, Inc.	259,470	0
Loan to Emergence Global Enterprises Inc.	0	(17,901)
Advances to CEN Biotech Ukraine LLC	(120,000)	(114,000)
Capitalized software development	(106,320)	0
Purchases of equipment	(23,213)	0
Proceeds from sale of equipment	0	1,801
Net cash provided by (used in) investing activities	9,937	(130,100)
Cash flows from financing activities
Repayment of loans payable - related parties	(50,000)	0
Issuance of convertible notes	522,830	499,000
Repayment of convertible notes	0	(30,000)
Issuance of convertible notes - related parties	48,000	0
Net cash provided by financing activities	520,830	469,000
Effect of exchange rate changes on cash	(3,973)	0
Net increase (decrease) in cash and cash equivalents	191,290	(1,849)
Cash and cash equivalents, beginning of year	1,908	3,757
Cash and cash equivalents, end of year	193,198	1,908
Supplemental cash flows disclosures
Cash paid for interest	25,818	75,963
Non-cash transactions - investing and financing activities
Issuance of common stock - settlement of interest	78,893	0
Issuance of common stock - settlement of accrued liability	13,390	58,500
Issuance of common stock - settlement of patent acquisition	2,042,500	0
Settlement of receivable from Emergence Global Enterprises Inc.	17,901	0
Waiver of conversion rights on convertible loans payable	1,462,484	0
Waiver of conversion rights on convertible loans payable - related parties	1,388,122	0
Transfer of convertible notes – related parties to convertible notes	102,395	0
Debt assumed by seller as part of lighting patent purchase	302,187	0
Issuance of note payable for services	0	19,000
Clear Com Media, Inc [Member]
Acquisition of Clear Com Media, Inc.:
Fair value of assets acquired	2,604,669	0
Issuance of common stock - acquisition of Clear Com Media, Inc.	2,120,000	0
Liabilities assumed	484,669	0
Convertible Debt [Member]
Non-cash transactions - investing and financing activities
Debt Instrument, Convertible, Beneficial Conversion Feature	198,239	0
Conversion of Convertible Notes into Common Stock [Member]
Non-cash transactions - investing and financing activities
Debt Conversion, Converted Instrument, Amount	5,173,785	0
Conversion of Related Party Convertible Notes into Common stock [Member]
Non-cash transactions - investing and financing activities
Debt Conversion, Converted Instrument, Amount	$ 946,368	$ 0